<!DOCTYPE html>
<html lang="" xml:lang="">
  <head>
    <title>Week 2: Healthcare Data: Open Data &amp; Reproducibility</title>
    <meta charset="utf-8" />
    <meta name="author" content="Charlotte Hadley" />
    <script src="week-02_slides_reproducibility_files/header-attrs/header-attrs.js"></script>
    <link href="week-02_slides_reproducibility_files/remark-css/default.css" rel="stylesheet" />
    <link href="week-02_slides_reproducibility_files/remark-css/ninjutsu.css" rel="stylesheet" />
    <script src="week-02_slides_reproducibility_files/xaringanExtra-progressBar/progress-bar.js"></script>
    <script src="week-02_slides_reproducibility_files/twitter-widget/widgets.js"></script>
    <link rel="stylesheet" href="css/lecture-styles.css" type="text/css" />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/animate.css/4.1.1/animate.min.css" type="text/css" />
    <link rel="stylesheet" href="assets/ninpo.css" type="text/css" />
  </head>
  <body>
    <textarea id="source">
class: center, middle, inverse, title-slide

.title[
# Week 2: Healthcare Data: Open Data &amp; Reproducibility
]
.author[
### <large>Charlotte Hadley</large>
]

---


class: split-two, with-thick-border border-black



<style>.xe__progress-bar__container {
  top:0;
  opacity: 1;
  position:absolute;
  right:0;
  left: 0;
}
.xe__progress-bar {
  height: 5px;
  background-color: #e10020;
  width: calc(var(--slide-current) / var(--slide-total) * 100%);
}
.remark-visible .xe__progress-bar {
  animation: xe__progress-bar__wipe 200ms forwards;
  animation-timing-function: cubic-bezier(.86,0,.07,1);
}
@keyframes xe__progress-bar__wipe {
  0% { width: calc(var(--slide-previous) / var(--slide-total) * 100%); }
  100% { width: calc(var(--slide-current) / var(--slide-total) * 100%); }
}</style>


.column.bg-main1[.content[
  .split-three[
 .row[.content[
 # 1. There's a reproducibility crisis
 ]]
  .row[.content[
 # 2. Everything you can do to help reproducibility
 ]]
   .row[.content[
 # 3. Understanding Open Access and Open Data
 ]]
 ]
]]

.column.bg-main1[.content.center.vmiddle[
  # 4. Acknowledging legal and funder requirements affecting reproduciblity
]]

---

class: inverse, center, middle

# "There's a reproducibility crisis in academia"

Have you heard this before?

---

# There is a reproduciblity crisis in academia

Back in 2005 a ground breaking paper by John Ioannidis [4] exposed an unsettling truth

&lt;center&gt;
&lt;img src='images/ioannidis-2005_most-published-research-findings-are-false.jpg' height='500px'/&gt;
&lt;/center&gt;

---

# There's still a crisis almost two decades later

Despite lots being written about the crisis... it's still here. And with the rise of 

&gt; *"machine learning can solve anything!"* 

... the crisis is evolving and getting more complicated, as reported by Douglas Heaven [6].

&lt;a href='https://www.technologyreview.com/2021/07/30/1030329/machine-learning-ai-failed-covid-hospital-diagnosis-pandemic/'&gt;&lt;img src='images/hundreds-of-covid-ai-tools.jpg' height='300px'/&gt;&lt;/a&gt;

---

# Reproducibility vs Replicability

Quite a lot of the time you'll see these two words used interchangeably - but they have specific meanings. The American Statistical Association (ASA) provides useful advice from Broman, et al. [7].

--

.pull-left[

&gt; Reproducibility: A study is reproducible if you can take the **original data and the computer code** used to analyze the data and reproduce all of the numerical findings from the study.

]

.pull-right[
&gt; Your module assessment must be reproducible - I must be able to run the code after it's submitted. 
]

---

# Reproducibility

&gt; Reproducibility: A study is reproducible if you can take the **original data and the computer code** used to analyze the data and reproduce all of the numerical findings from the study.

Reproducibility is something to think about from the start of a research project:

- Plan to record and document all *processes* in data collection, wrangling and analysis

- While performing the research keep track of all the things you do - particularly with data!

- When writing up your research ensure that all necessary materials to reproduce your findings are made available.

&gt; Later in this lecture and the workshop we'll look at specific advice for achieving this.

---

# Replicability

&gt; Replicability: This is the act of repeating an entire study, **independently of the original investigator** without the use of original data (but generally using the same methods)

This is a slightly harder topic to conceptualise and much of the lack of replicability comes from what we call "questionable research practices" (QRPs)

&gt; ... these misbehaviours lie somewhere on a continuum between scientific fraud, bias, and simple carelessness, so their direct inclusion in the “falsification” category is debatable, although their negative impact on research can be dramatic
&gt;
&gt; Fanelli [12]

---

# Questionable Research Practices

There are lots of different ways to summarise common QRPs but I quite like this table from 2012 by John, et al. [8].

<div id="txqcunmvtb" style="overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
<style>html {
  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;
}

#txqcunmvtb .gt_table {
  display: table;
  border-collapse: collapse;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#txqcunmvtb .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#txqcunmvtb .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#txqcunmvtb .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 0;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#txqcunmvtb .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#txqcunmvtb .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#txqcunmvtb .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#txqcunmvtb .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#txqcunmvtb .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#txqcunmvtb .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#txqcunmvtb .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#txqcunmvtb .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
}

#txqcunmvtb .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#txqcunmvtb .gt_from_md > :first-child {
  margin-top: 0;
}

#txqcunmvtb .gt_from_md > :last-child {
  margin-bottom: 0;
}

#txqcunmvtb .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#txqcunmvtb .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#txqcunmvtb .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#txqcunmvtb .gt_row_group_first td {
  border-top-width: 2px;
}

#txqcunmvtb .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#txqcunmvtb .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#txqcunmvtb .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#txqcunmvtb .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#txqcunmvtb .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#txqcunmvtb .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#txqcunmvtb .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#txqcunmvtb .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#txqcunmvtb .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#txqcunmvtb .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-left: 4px;
  padding-right: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#txqcunmvtb .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#txqcunmvtb .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#txqcunmvtb .gt_left {
  text-align: left;
}

#txqcunmvtb .gt_center {
  text-align: center;
}

#txqcunmvtb .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#txqcunmvtb .gt_font_normal {
  font-weight: normal;
}

#txqcunmvtb .gt_font_bold {
  font-weight: bold;
}

#txqcunmvtb .gt_font_italic {
  font-style: italic;
}

#txqcunmvtb .gt_super {
  font-size: 65%;
}

#txqcunmvtb .gt_two_val_uncert {
  display: inline-block;
  line-height: 1em;
  text-align: right;
  font-size: 60%;
  vertical-align: -0.25em;
  margin-left: 0.1em;
}

#txqcunmvtb .gt_footnote_marks {
  font-style: italic;
  font-weight: normal;
  font-size: 75%;
  vertical-align: 0.4em;
}

#txqcunmvtb .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#txqcunmvtb .gt_slash_mark {
  font-size: 0.7em;
  line-height: 0.7em;
  vertical-align: 0.15em;
}

#txqcunmvtb .gt_fraction_numerator {
  font-size: 0.6em;
  line-height: 0.6em;
  vertical-align: 0.45em;
}

#txqcunmvtb .gt_fraction_denominator {
  font-size: 0.6em;
  line-height: 0.6em;
  vertical-align: -0.05em;
}
</style>
<table class="gt_table">
  
  <thead class="gt_col_headings">
    <tr>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Questionable Research Practice</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1">Self-admission rate&lt;br&gt;(Amongst 2,000 pysychologists)</th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td class="gt_row gt_left">In a paper, failing to report all of a study’s dependent measures</td>
<td class="gt_row gt_right">63.4%</td></tr>
    <tr><td class="gt_row gt_left">Deciding whether to collect more data after looking to see whether the results were significant</td>
<td class="gt_row gt_right">55.9%</td></tr>
    <tr><td class="gt_row gt_left">In a paper, selectively reporting studies that “worked”</td>
<td class="gt_row gt_right">45.8%</td></tr>
    <tr><td class="gt_row gt_left">Deciding whether to exclude data after looking at the impact of doing so on the results</td>
<td class="gt_row gt_right">38.2%</td></tr>
    <tr><td class="gt_row gt_left">In a paper, failing to report all of a study’s conditions</td>
<td class="gt_row gt_right">27.7%</td></tr>
    <tr><td class="gt_row gt_left">In a paper, reporting an unexpected finding as having been predicted from the start</td>
<td class="gt_row gt_right">27.0%</td></tr>
    <tr><td class="gt_row gt_left">In a paper, “rounding off” a p value (e.g., reporting that a p value of .054 is less than .05)</td>
<td class="gt_row gt_right">22.0%</td></tr>
    <tr><td class="gt_row gt_left">Stopping collecting data earlier than planned because one found the result that one had been looking for</td>
<td class="gt_row gt_right">15.6%</td></tr>
    <tr><td class="gt_row gt_left">In a paper, claiming that results are unaffected by demographic variables (e.g., gender) when one is actually unsure (or knows that they do)</td>
<td class="gt_row gt_right">3.0%</td></tr>
    <tr><td class="gt_row gt_left">Falsifying data</td>
<td class="gt_row gt_right">0.6%</td></tr>
  </tbody>
  
  
</table>
</div>

---

# Questionable Research Practices and P-hacking

The majority of these QRPs can be categorised as "P-hacking" or more fully, hacking the P-value.

<div id="tdepqlkbmm" style="overflow-x:auto;overflow-y:auto;width:auto;height:auto;">
<style>html {
  font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Helvetica Neue', 'Fira Sans', 'Droid Sans', Arial, sans-serif;
}

#tdepqlkbmm .gt_table {
  display: table;
  border-collapse: collapse;
  margin-left: auto;
  margin-right: auto;
  color: #333333;
  font-size: 16px;
  font-weight: normal;
  font-style: normal;
  background-color: #FFFFFF;
  width: auto;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #A8A8A8;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #A8A8A8;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
}

#tdepqlkbmm .gt_heading {
  background-color: #FFFFFF;
  text-align: center;
  border-bottom-color: #FFFFFF;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#tdepqlkbmm .gt_title {
  color: #333333;
  font-size: 125%;
  font-weight: initial;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-color: #FFFFFF;
  border-bottom-width: 0;
}

#tdepqlkbmm .gt_subtitle {
  color: #333333;
  font-size: 85%;
  font-weight: initial;
  padding-top: 0;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-color: #FFFFFF;
  border-top-width: 0;
}

#tdepqlkbmm .gt_bottom_border {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#tdepqlkbmm .gt_col_headings {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
}

#tdepqlkbmm .gt_col_heading {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 6px;
  padding-left: 5px;
  padding-right: 5px;
  overflow-x: hidden;
}

#tdepqlkbmm .gt_column_spanner_outer {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: normal;
  text-transform: inherit;
  padding-top: 0;
  padding-bottom: 0;
  padding-left: 4px;
  padding-right: 4px;
}

#tdepqlkbmm .gt_column_spanner_outer:first-child {
  padding-left: 0;
}

#tdepqlkbmm .gt_column_spanner_outer:last-child {
  padding-right: 0;
}

#tdepqlkbmm .gt_column_spanner {
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: bottom;
  padding-top: 5px;
  padding-bottom: 5px;
  overflow-x: hidden;
  display: inline-block;
  width: 100%;
}

#tdepqlkbmm .gt_group_heading {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
}

#tdepqlkbmm .gt_empty_group_heading {
  padding: 0.5px;
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  vertical-align: middle;
}

#tdepqlkbmm .gt_from_md > :first-child {
  margin-top: 0;
}

#tdepqlkbmm .gt_from_md > :last-child {
  margin-bottom: 0;
}

#tdepqlkbmm .gt_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  margin: 10px;
  border-top-style: solid;
  border-top-width: 1px;
  border-top-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 1px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 1px;
  border-right-color: #D3D3D3;
  vertical-align: middle;
  overflow-x: hidden;
}

#tdepqlkbmm .gt_stub {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
}

#tdepqlkbmm .gt_stub_row_group {
  color: #333333;
  background-color: #FFFFFF;
  font-size: 100%;
  font-weight: initial;
  text-transform: inherit;
  border-right-style: solid;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
  padding-left: 5px;
  padding-right: 5px;
  vertical-align: top;
}

#tdepqlkbmm .gt_row_group_first td {
  border-top-width: 2px;
}

#tdepqlkbmm .gt_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#tdepqlkbmm .gt_first_summary_row {
  border-top-style: solid;
  border-top-color: #D3D3D3;
}

#tdepqlkbmm .gt_first_summary_row.thick {
  border-top-width: 2px;
}

#tdepqlkbmm .gt_last_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#tdepqlkbmm .gt_grand_summary_row {
  color: #333333;
  background-color: #FFFFFF;
  text-transform: inherit;
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
}

#tdepqlkbmm .gt_first_grand_summary_row {
  padding-top: 8px;
  padding-bottom: 8px;
  padding-left: 5px;
  padding-right: 5px;
  border-top-style: double;
  border-top-width: 6px;
  border-top-color: #D3D3D3;
}

#tdepqlkbmm .gt_striped {
  background-color: rgba(128, 128, 128, 0.05);
}

#tdepqlkbmm .gt_table_body {
  border-top-style: solid;
  border-top-width: 2px;
  border-top-color: #D3D3D3;
  border-bottom-style: solid;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
}

#tdepqlkbmm .gt_footnotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#tdepqlkbmm .gt_footnote {
  margin: 0px;
  font-size: 90%;
  padding-left: 4px;
  padding-right: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#tdepqlkbmm .gt_sourcenotes {
  color: #333333;
  background-color: #FFFFFF;
  border-bottom-style: none;
  border-bottom-width: 2px;
  border-bottom-color: #D3D3D3;
  border-left-style: none;
  border-left-width: 2px;
  border-left-color: #D3D3D3;
  border-right-style: none;
  border-right-width: 2px;
  border-right-color: #D3D3D3;
}

#tdepqlkbmm .gt_sourcenote {
  font-size: 90%;
  padding-top: 4px;
  padding-bottom: 4px;
  padding-left: 5px;
  padding-right: 5px;
}

#tdepqlkbmm .gt_left {
  text-align: left;
}

#tdepqlkbmm .gt_center {
  text-align: center;
}

#tdepqlkbmm .gt_right {
  text-align: right;
  font-variant-numeric: tabular-nums;
}

#tdepqlkbmm .gt_font_normal {
  font-weight: normal;
}

#tdepqlkbmm .gt_font_bold {
  font-weight: bold;
}

#tdepqlkbmm .gt_font_italic {
  font-style: italic;
}

#tdepqlkbmm .gt_super {
  font-size: 65%;
}

#tdepqlkbmm .gt_two_val_uncert {
  display: inline-block;
  line-height: 1em;
  text-align: right;
  font-size: 60%;
  vertical-align: -0.25em;
  margin-left: 0.1em;
}

#tdepqlkbmm .gt_footnote_marks {
  font-style: italic;
  font-weight: normal;
  font-size: 75%;
  vertical-align: 0.4em;
}

#tdepqlkbmm .gt_asterisk {
  font-size: 100%;
  vertical-align: 0;
}

#tdepqlkbmm .gt_slash_mark {
  font-size: 0.7em;
  line-height: 0.7em;
  vertical-align: 0.15em;
}

#tdepqlkbmm .gt_fraction_numerator {
  font-size: 0.6em;
  line-height: 0.6em;
  vertical-align: 0.45em;
}

#tdepqlkbmm .gt_fraction_denominator {
  font-size: 0.6em;
  line-height: 0.6em;
  vertical-align: -0.05em;
}
</style>
<table class="gt_table">
  
  <thead class="gt_col_headings">
    <tr>
      <th class="gt_col_heading gt_columns_bottom_border gt_left" rowspan="1" colspan="1">Questionable Research Practice</th>
      <th class="gt_col_heading gt_columns_bottom_border gt_right" rowspan="1" colspan="1">Self-admission rate&lt;br&gt;(Amongst 2,000 pysychologists)</th>
    </tr>
  </thead>
  <tbody class="gt_table_body">
    <tr><td class="gt_row gt_left">In a paper, failing to report all of a study’s dependent measures</td>
<td class="gt_row gt_right">63.4%</td></tr>
    <tr><td class="gt_row gt_left" style="color: #FF0000;">Deciding whether to collect more data after looking to see whether the results were significant</td>
<td class="gt_row gt_right" style="color: #FF0000;">55.9%</td></tr>
    <tr><td class="gt_row gt_left" style="color: #FF0000;">In a paper, selectively reporting studies that “worked”</td>
<td class="gt_row gt_right" style="color: #FF0000;">45.8%</td></tr>
    <tr><td class="gt_row gt_left" style="color: #FF0000;">Deciding whether to exclude data after looking at the impact of doing so on the results</td>
<td class="gt_row gt_right" style="color: #FF0000;">38.2%</td></tr>
    <tr><td class="gt_row gt_left">In a paper, failing to report all of a study’s conditions</td>
<td class="gt_row gt_right">27.7%</td></tr>
    <tr><td class="gt_row gt_left" style="color: #FF0000;">In a paper, reporting an unexpected finding as having been predicted from the start</td>
<td class="gt_row gt_right" style="color: #FF0000;">27.0%</td></tr>
    <tr><td class="gt_row gt_left" style="color: #FF0000;">In a paper, “rounding off” a p value (e.g., reporting that a p value of .054 is less than .05)</td>
<td class="gt_row gt_right" style="color: #FF0000;">22.0%</td></tr>
    <tr><td class="gt_row gt_left" style="color: #FF0000;">Stopping collecting data earlier than planned because one found the result that one had been looking for</td>
<td class="gt_row gt_right" style="color: #FF0000;">15.6%</td></tr>
    <tr><td class="gt_row gt_left">In a paper, claiming that results are unaffected by demographic variables (e.g., gender) when one is actually unsure (or knows that they do)</td>
<td class="gt_row gt_right">3.0%</td></tr>
    <tr><td class="gt_row gt_left">Falsifying data</td>
<td class="gt_row gt_right">0.6%</td></tr>
  </tbody>
  
  
</table>
</div>

---

# What is the p-value?

We're going to talk about p-values **A LOT** in week 10. For now I wanted to borrow a slide from [Lucy D'Agostino McGowan](https://orcid.org/0000-0001-7297-9359)'s talk which is [well explained in this Twitter thread](https://twitter.com/LucyStats/status/1519314859258789890?s=20&amp;t=nXMSyN2NWsEj5Ns5a4Gd2Q).

&lt;center&gt;
&lt;img src='images/p-values_lucy-mcgowan-slide.jpeg' height='500px'/&gt;
&lt;center&gt;

---

# How folks treat the p-value

.pull-left[

In some situations "p-values" are considered infallible evidence of an effect or the conclusion of a study.

There are lots of different p-value thresholds, but the most common in healthcare data science is 0.05

Researchers who find their study results in values *just above* 0.05 will explore ways to get the value below 0.05

&gt; That's p-value hacking.

]

.pull-right[
&lt;img src='images/p-values_xkcd_p-value-scale.png' height='500px'/&gt;
&lt;a href='https://xkcd.com/1478/'&gt;https://xkcd.com/1478/&lt;/a&gt;
]

---

# P-hacking

In 2019 Aschwanden [9] published an article in Wired.com titled ["We're All 'P-Hacking' Now"](https://www.wired.com/story/were-all-p-hacking-now/) which I highly recommend reading.

It highlights an excellent study by Simmons, et al. [10] that was able to use p-value hacking to make two increasingly absurd conclusions:

&gt; Study 1: Listening to a children's song ("Hot Potato" by *The Wiggles*) makes people **feel** older.
&gt;
&gt; Study 2: Listening to a song about old age ("When I'm Sixty-Four" by *The Beatles*) makes people **actually** younger.

... I really like this paper because it makes very clear recommendations to researchers and reviewers.

---

class: inverse, center, middle

# Have you ever read an academic paper?

## [doi.org/10.1177/0956797611417632](https://doi.org/10.1177/0956797611417632)

---

# Reading papers is a skill

Always expect to read a paper **multiple** times and make notes.

We can kind of neatly split papers into two different types:

.pull-left[

[Clinical trials like](https://doi.org/:10.1136/bmjopen-2020-044369) this one from Hu, et al. [11] 

&lt;img src='images/screenshot_medical-study.jpg'/&gt;

]


.pull-right[

In some clinical trials the abstract includes **a lot of structured information** - it depends on the publisher.

Some journals like BMJ Open even include study strengths and weaknesses.

Read these papers in this order:

- Abstract

- Tables and/or figures

- Conclusions

- Introduction

]

---

# Reading papers is a skill

.pull-left[

But **most** papers [look this one](https://doi.org/10.1177/0956797611417632) from Simmons, et al. [10] 

&lt;img src='images/screenshot_non-medical-study.jpg'/&gt;

]

.pull-right[

In fact, not all medical trials have such nice to read abstracts.

But the reading order is the same:

- Abstract

- Tables and/or figures

- Conclusions

- Introduction

]

---

class: highlight-last-item

# Reading papers is a skill

- On your first pass of a paper you are trying to understand if the paper is relevant and provides substantial information and/or evidence for your needs.

--

- Often it will take another 1 or 2 passes to understand the **results** of the paper.

--

- It usually takes even more effort to understand the **methods** of the paper

   - Methodology information is often provided in "supplementary materials"
   
   - But unfortunately a good portion of the time you won't find sufficient information to fully understand the methodology because of **poor reproducibility**.

--

&gt; Learning about replicability and reproducibility now will help you in understanding the existing literature **and** prepare you to succeed in a research career later on.

---

class: highlight-last-item

# Reading papers is a skill

If you decide to go into a research career you'll likely be reading 10+ papers a week.

I'd highly recommend investing in learning speed reading early in your career. 

There's lots of [very interesting] eye tracking and neurological research into how we read and evidenced methodologies for speed reading that are nicely summarised by Clifton, et al. [13]

&lt;hr&gt;

.pull-left[
BCU gives you free access to LinkedIn Learning.

Go to [linkedin.com/learning-login/](https://www.linkedin.com/learning-login/) and login with your BCU email address.
]

.pull-right[
&lt;img src='images/li-course_speed-reading.jpg' width='100%'/&gt;
]

---

class: inverse, center, middle

# ... let's get back to p-hacking

---

# Fighting p-hacking with pre-registration

So far I've been speaking about the academic literature at large.

But let's look specifically at clinical trials.

&gt; All clinical trials began after July 1st 2005 are explicitly required to be **registered**&lt;sup&gt;1&lt;/sup&gt; in order to be published in [**all biomedical journals**](https://www.icmje.org/about-icmje/) overseen by the International Committee of Medical Journal Editors (ICMJE)  [14].
&gt;
&gt; This is independent of the country in which the trial took place. 

.footnote[
[1] Frustratingly in the clinical trials community we use the phrase "registration" but everyone else says "pre-registration".
]

---

# National Institutes of Health (NIH) and registration

From a cursory search for clinical trial registration information you might come to the conclusion that the advice is only appropriate for studies in the US.

&gt; That is not true.

In 2008 the World Medical Association [15] updated the *Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects* to include a paragraph about registration.

&gt; 19\. Every clinical trial must be registered in a publicly accessible database before
recruitment of the first subject.

---

# International advice on clinical trials

The NIH provides a really useful tool for comparing the clinical research regulations from several countries:

https://clinregs.niaid.nih.gov/country/united-kingdom

---

# UK trial registration

Despite these "requirements" violations are still common as detailed in Bradley, et al. [16].

However, the UK has announced new infrastructure requiring 100% clinical trial registration via a collaboration between the Human Research Authority and [the ISRCTN registry](https://www.isrctn.com/) which is detailed by Bruckner [17].

---

# Registration to "Reduce waste"

For unexplainable reasons there is a lot written about registration of trials "reducing research waste" as it helps reduce duplication of studies.

While there are elements of truth to this, the big takeaway is pre-registration helps prevent Questionable Research Practices.

&gt; In fact it's the reason why GSK reached a $2.5million settlement in 2004

---

# GlaxoSmithKline &amp; Clinical Trial Registration

GSK chose to settle a civil case instead of engaging in an expensive legal battle over "repeated and persistent fraud" concerning the use of paroxetine in treating depression in adolescents.

As detailed by Dyer [18]:

- Two studies showed no benefit to using paroxetine when compared with placebo.

- Three studies found evidence for an increase in suicidal thoughts and behaviour.

Internal company documents confirmed the suppression of these results:

&gt; “it would be commercially unacceptable to include a statement that efficacy had not been demonstrated, as this would undermine the profile of paroxetine.”
&gt;
&gt; Spurgeon [19]

---

# Pre-registration for all studies

There's a growing body of researchers both actually doing pre-registration and calling for it in all disciplines - particularly those that intersect with healthcare.

- Simmons, et al. [10] have been running [aspredicted.org](https://aspredicted.org/) since 2015 to help authors to create pre-registration reports.

- The [Centre for Open Science](https://www.cos.io) encourages pre-registration on OSF and has in the past run a [Preregistration Challenge with a monetary prize](https://osf.io/x5w7h/wiki/06%20LeaderBoard/?hsCtaTracking=2f25be73-35de-4b95-93e8-4f08acc42332%7Cf2024186-54bb-4626-baab-1785d2f9d71a).

- I highly recommend reading Nosek, et al. [20] which gives a great overview of pre-registration and walk through multiple example of how it works in practice. 
&gt; At the moment there's nothing binding you to pre-register non-clinical trials but this topic is simmering away in the background

---

# Prediction markets and replication studies

&gt; In prediction markets, investors make predictions of future events by buying shares in the outcome of the event and the market price indicates what the crowd thinks the probability of the event is.
&gt;
&gt; [Harvard Press Release](https://www.seas.harvard.edu/news/2015/11/markets-science)

--

This was first applied to predicting replicability of research results in 2015 by Dreber, et al. [1].

There is now evidence for these markets being a reliable estimate of predictability Camerer, et al. [2].

&gt; Prof. Anna Dreber gives an excellent 40minute overview of replication prediction markets here - https://youtu.be/a5rFDKB1aZc?t=1036

---

# A final word on replicability studies

Most (if not all) of studies about replicability are deeply technical and rely on statistical methods we don't have time to cover in this course.

This includes the foundational paper "Why Most Published Research Findings Are False" by Ioannidis [4].

&gt; Your assessment does not require you to understand or replicate any of the methodologies behind replicability studies.

---

# Reproducibility

Let's get back to the ASA reproducibility recommendations from Broman, et al. [7].

&gt; Reproducibility: A study is reproducible if you can take the **original data and the computer code** used to analyze the data and reproduce all of the numerical findings from the study.

In order for reproducibility to be *possible* we need the original data to be accessible - we need **Open Data**.

---

class: middle, center, inverse

# Open Data

---

# Most papers don't provide their data

More often than papers simply **do not provide** the data that they:

- Use to create charts and tables

- Use to perform statistical tests

- Use to generate their conclusions

&gt; These papers are the antithesis of reproducible.

---

# "Data available on request"

It's common to see the phrase "data available on request" but that's frequently meaningless:

&gt; "Data requests to authors are successful in 27–59% of cases, whereas the request is ignored in 14–41% cases"
&gt;
&gt; Tedersoo, et al. [23]

Even in cases where data is returned it's often insufficient for reproducibility, Roche, et al. [30]:

- "Data" might actually be screenshots of charts stored in an Excel workbook

- "Data" might be stored in other "non-machine-readable" formats like PDF or images

- "Data" might only be provided in the post analysis form

---

# Researchers have confusing opinions

In one of the earliest, biggest and most cited studies in data sharing from 2011 by Tenopir, et al. [24] surveyed 1,329 scientists found that

&gt; "Most respondents (at least 60% across disciplines) agree that lack of access to data generated by other researchers or institutions is a major impediment to progress in science."

... but

&gt; "A majority of all respondents indicate they are not willing to place all of their data in central repositories with no restrictions"

These findings have been replicated again, and again.

---

# Open Data helps everyone

.pull-left[

**Researchers**

- Open Data helps reproduce previous studies

- Open Data means researchers can do **new** studies, including meta analyses.

&lt;hr&gt;

- Open Data gives an additional way researchers can be cited

- There is clear evidence Open Data is linked with higher citation rates, eg Colavizza, et al. [25].


]

--

.pull-right[

**Society**

- The coordinated global COVID-19 response benefited significantly from Open Data portals  [26].

- Reducing energy consumption of buildings based in occupancy from public datasets Roth, et al. [27].

- Emergency planning via use of the Behavioral Risk Factor Surveillance System (BRFSS)  [28]


]

.small[
&gt; You can find *some* healthcare specific examples on the course website [eng7218.netlify.app/resources/open-data](https://eng7218.netlify.app/resources/open-data). Please do research your own - and consider sharing them with the group.
]

---

# Open Data vs Big Data

Big Data is great. It's the driver behind the Internet of Things and much of modern healthcare technology. But in most circumstances it is **not** Open Data.

&lt;a href='http://opendefinition.org/'&gt;&lt;img src='images/screenshot_open-definition.jpg' height='400px'/&gt;&lt;/a&gt;

Screenshot of  [29]

---

# Open Data short definition

Let's minimise these definitions:

&gt; Open data must be..

- Legally open. The data must be subject to an open data license

- Technically open.

  - Data files must be machine-readable and non-proprietary, which often means *plain text*.
  
  - Accessible from a public server without password protection

&gt; Open data must be open to humans and computers.

---

# Open Data licenses

In most cases the [Creative Commons' "Choose a license tool"](https://creativecommons.org/choose/) is the best and easiest choice if you have a **dataset** you want to make into Open Data.

- The CC0 license is the most permissive license.

There are special Open Data licenses used by Governmental/Charity organisations designed to waive liability for use, eg the [Open Government License](https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/) from the UK Government [32] 

&gt; In general it's best to use data licenses for data and software licenses for software.

---

# Open Data examples

There are **SO MANY** different sources (or publishers) of Open Data, for a good sample checkout the [Open Data Essentials page from the World Bank [34]](http://opendatatoolkit.worldbank.org/en/essentials.html).

.center[
&lt;img src='images/screenshot_open-data-essentials.jpg' height='450px'/&gt;
]

---

# Open Data and Health Data

Open Data is awesome. But if we're responsible for data that can identify individuals or groups we have a [legal] duty of care to protect that data.

In the UK we have the [Data Protection Act](https://www.legislation.gov.uk/ukpga/2018/12/contents/enacted) (legislation.gov.uk [36]) which is the UK's implementation of the General Data Protection Regulation (GDPR).

&gt; In week 6 we will discuss GDPR and the Data Protection Act in the context of anonmyising data. 
&gt; 
&gt; This isn't a course in the law school so we won't go *hard* into the definitions. But there are some things we need to discuss.

---

# Open Data and Health Data

In the DPA (legislation.gov.uk [36]) there are 6 different types of sensitive data - I'm highlighting the ones that cover data that you might reasonably collect and consider "health data".

.small[
- (a) the processing of personal data revealing racial or ethnic origin, .de-emphasis[political opinions, religious or philosophical beliefs or trade union membership;]

- (b) the processing of genetic data for the purpose of uniquely identifying an individual;

- (c) the processing of biometric data for the purpose of uniquely identifying an individual;

- (d) the processing of data concerning health;

- (e) the processing of data concerning an individual’s sex life or sexual orientation;

- .de-emphasis[(f) the processing of personal data as to [commission or alleged commission of an offence]]
]

&gt; There's some recursion, so let's pull out the definitions of "health data" from Part 7 Section 205 and list everything together

---

# Open Data and Health Data

Part 7 Section 205 defines the following

.small[
- **“biometric data”** means personal data resulting from specific technical processing relating to the physical, physiological or behavioural characteristics of an individual, which allows or confirms the unique identification of that individual, such as facial images or dactyloscopic data;

- **“data concerning health”** means personal data relating to the physical or mental health of an individual, including the provision of health care services, which reveals information about his or her health status;

- **“genetic data”** means personal data relating to the inherited or acquired genetic characteristics of an individual which gives unique information about the physiology or the health of that individual and which results, in particular, from an analysis of a biological sample from the individual in question;
]

But we should also still include:

.small[
- (a) the processing of personal data revealing racial or ethnic origin,

- (e) the processing of data concerning an individual’s sex life or sexual orientation;
]

---

# Open Data and Health Data

There's more [reader friendly documentation about health data and DPA 2018](https://ico.org.uk/for-organisations/guide-to-data-protection/guide-to-the-general-data-protection-regulation-gdpr/right-of-access/health-data/#healthdata7) from the Information Commissioner's Office [37].

We'll talk about this more later.

---

# How do we create Open Data?



---
.pull-left[
- Protected characteristics
]

.pull-right[
- age
- gender reassignment
- being pregnant or on maternity leave
- disability
- race including colour, nationality, ethnic or national origin
- sex
- sexual orientation
]

---

# Open Data outside of academia

There are SO many Open Data portals!



---

# Dragons (TO BE ADDED!)

---

# Open Access




---

# How to cite 

---

# Aside: Press Releases really suck

Earlier I linked to a [Harvard Press Release about prediction markets for replicability](https://www.seas.harvard.edu/news/2015/11/markets-science).

It's a perfect example of why University press releases often suck.

- The article does not give the title of the paper

- The article does not give the link to the paper



---

# Aside: Difficulty citing white papers

The Turing Report by \noopsortborzyskowskivon
Borzyskowski, et al. [5] I mentioned earlier is a great example of adding a non-traditional publication to Zotero.

1. Use "Report" as type

1. Manually add names

1. Infer the date of the report from the URL `turing.ac.uk/.../2021-06/...pdf`

1. Add "Accessed field"

1. Add URL

1. Add Institute


---

# Why are we learning all of this now?


```r
tweetrmd::tweet_embed("https://twitter.com/charliejhadley/status/1559534088838647808?s=20&amp;t=M0f0BvpbqLiKpDxBHiJy7w")
```

<blockquote class="twitter-tweet" data-width="550" data-lang="en" data-dnt="true" data-theme="light"><p lang="en" dir="ltr">When did you as a student/academic researcher first learn about reproducible research methods?<a href="https://twitter.com/hashtag/reproducibleresearch?src=hash&amp;ref_src=twsrc%5Etfw">#reproducibleresearch</a> <a href="https://twitter.com/hashtag/reproducibility?src=hash&amp;ref_src=twsrc%5Etfw">#reproducibility</a><br><br>(More polls on this below, sorry they don’t have a “show results option”)</p>&mdash; Charlotte (@charliejhadley) <a href="https://twitter.com/charliejhadley/status/1559534088838647808?ref_src=twsrc%5Etfw">August 16, 2022</a></blockquote>


---

# ASSESSMENT STUFF

•	What is “health data”? 
•	Why is it important to government, industry and academia that health datasets are made available?
•	What are some of the benefits to individuals and groups in making health datasets open?


---

# References Page 1

.references[

[1] _CDC - BRFSS Annual Survey Data_. https://www.cdc.gov/brfss/annual\_ data/annual\_ data.htm. Aug. 2021.

[2] _DATA in the Time of COVID-19_. Nov. 2020.

[3] _Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (ICMJE)_.
https://www.icmje.org/icmje-recommendations.pdf. 2022.

[4] _The Open Definition - Open Definition - Defining Open in Open Data, Open Content and Open Knowledge_.
http://opendefinition.org/. Aug. 2022.

[5] I. \noopsortborzyskowskivon Borzyskowski et al. _Data Science and AI in the Age of COVID-19_. Tech. rep. The Alan Turing
Institute, Jun. 2021, pp. 1-13.

[6] C. Aschwanden. "We're All 'P-Hacking' Now". In: _Wired_ (Nov. 2019).

[7] D. J. Bem. "Feeling the Future: Experimental Evidence for Anomalous Retroactive Influences on Cognition and Affect". In:
_Journal of Personality and Social Psychology_ 100.3 (2011), pp. 407-425. ISSN: 1939-1315. DOI: 10.1037/a0021524.

[8] S. H. Bradley et al. "Automatic Registration for UK Trials". In: _BMJ_ 376 (Jan. 2022), p. o41. ISSN: 1756-1833. DOI:
10.1136/bmj.o41.

[9] K. Broman et al. _Recommendations to Funding Agencies for Supporting Reproducible Research_. Tech. rep. American
Statistial Association, Jan. 2017, pp. 1-4.

[10] T. Bruckner. _UK Launches New System to Achieve 100% Clinical Trial Registration (Updated)_.
https://www.transparimed.org/single-post/uk-clinical-trial-registration. Oct. 2021.

]

---

# References Page 2

.references[

[1] C. F. Camerer et al. "Evaluating the Replicability of Social Science Experiments in Nature and Science between 2010 and
2015". In: _Nature Human Behaviour_ 2.9 (Sep. 2018), pp. 637-644. ISSN: 2397-3374. DOI: 10.1038/s41562-018-0399-z.

[2] C. Clifton et al. "Eye Movements in Reading and Information Processing: Keith Rayner's 40year Legacy". In: _Journal of
Memory and Language_ 86 (Jan. 2016), pp. 1-19. ISSN: 0749-596X. DOI: 10.1016/j.jml.2015.07.004.

[3] G. Colavizza et al. "The Citation Advantage of Linking Publications to Research Data". In: _PLOS ONE_ 15.4 (Apr. 2020), p.
e0230416. ISSN: 1932-6203. DOI: 10.1371/journal.pone.0230416.

[4] W. Douglas Heaven. _Hundreds of AI Tools Have Been Built to Catch Covid. None of Them Helped._
https://www.technologyreview.com/2021/07/30/1030329/machine-learning-ai-failed-covid-hospital-diagnosis-pandemic/. Jul. 2021.

[5] A. Dreber et al. "Using Prediction Markets to Estimate the Reproducibility of Scientific Research". In: _Proceedings of
the National Academy of Sciences_ 112.50 (Dec. 2015), pp. 15343-15347. DOI: 10.1073/pnas.1516179112.

[6] O. Dyer. "GlaxoSmithKline Faces US Lawsuit over Concealment of Trial Results". In: _BMJ : British Medical Journal_
328.7453 (Jun. 2004), p. 1395. ISSN: 0959-8138.

[7] D. Fanelli. "How Many Scientists Fabricate and Falsify Research? A Systematic Review and Meta-Analysis of Survey Data".
In: _PLOS ONE_ 4.5 (May. 2009), p. e5738. ISSN: 1932-6203. DOI: 10.1371/journal.pone.0005738.

[8] Y. Hu et al. "Factors Influencing Self-Care Behaviours of Patients with Type 2 Diabetes in China Based on the Health
Belief Model: A Cross-Sectional Study". In: _BMJ Open_ 12.8 (Aug. 2022), p. e044369. ISSN: 2044-6055, 2044-6055. DOI:
10.1136/bmjopen-2020-044369.

[9] Information Commissioner's Office. _Health Data_.
https://ico.org.uk/for-organisations/guide-to-data-protection/guide-to-the-general-data-protection-regulation-gdpr/right-of-access/health-data/.
Jan. 2021.

[10] J. P. A. Ioannidis. "Why Most Published Research Findings Are False". In: _PLoS Medicine_ 2.8 (Aug. 2005), p. e124. ISSN:
1549-1676. DOI: 10.1371/journal.pmed.0020124.

]

---

# References Page 3

.references[

[1] L. K. John et al. "Measuring the Prevalence of Questionable Research Practices With Incentives for Truth Telling". In:
_Psychological Science_ 23.5 (May. 2012), pp. 524-532. ISSN: 0956-7976, 1467-9280. DOI: 10.1177/0956797611430953.

[2] R. King. _How to Avoid Making an Excel Mistake like Rogoff and Reinhart_.
https://qz.com/75119/how-to-avoid-making-an-excel-mistake-like-rogoff-and-reinhart/. Apr. 2013.

[3] legislation.gov.uk. _Data Protection Act 2018_. https://www.legislation.gov.uk/ukpga/2018/12/contents/enacted. 2022.

[4] B. A. Nosek et al. "The Preregistration Revolution". In: _Proceedings of the National Academy of Sciences_ 115.11 (Mar.
2018), pp. 2600-2606. DOI: 10.1073/pnas.1708274114.

[5] C. M. Reinhart et al. "Growth in a Time of Debt". In: _American Economic Review_ 100.2 (May. 2010), pp. 573-578. ISSN:
0002-8282. DOI: 10.1257/aer.100.2.573.

[6] D. G. Roche et al. "Public Data Archiving in Ecology and Evolution: How Well Are We Doing?" In: _PLOS Biology_ 13.11 (Nov.
2015), p. e1002295. ISSN: 1545-7885. DOI: 10.1371/journal.pbio.1002295.

[7] J. Roth et al. "Examining the Feasibility of Using Open Data to Benchmark Building Energy Usage in Cities: A Data Science
and Policy Perspective". In: _Energy Policy_ 139 (Apr. 2020), p. 111327. ISSN: 0301-4215. DOI: 10.1016/j.enpol.2020.111327.

[8] J. P. Simmons et al. "False-Positive Psychology: Undisclosed Flexibility in Data Collection and Analysis Allows Presenting
Anything as Significant". In: _Psychological Science_ 22.11 (Nov. 2011), pp. 1359-1366. ISSN: 0956-7976. DOI:
10.1177/0956797611417632.

[9] D. Spurgeon. "GlaxoSmithKline Staff Told Not to Publicise Ineffectiveness of Its Drug". In: _BMJ : British Medical
Journal_ 328.7437 (Feb. 2004), p. 422. ISSN: 0959-8138.

[10] L. Tedersoo et al. "Data Sharing Practices and Data Availability upon Request Differ across Scientific Disciplines". In:
_Scientific Data_ 8.1 (Jul. 2021), p. 192. ISSN: 2052-4463. DOI: 10.1038/s41597-021-00981-0.

]
    </textarea>
<style data-target="print-only">@media screen {.remark-slide-container{display:block;}.remark-slide-scaler{box-shadow:none;}}</style>
<script src="https://remarkjs.com/downloads/remark-latest.min.js"></script>
<script src="js/macros.js"></script>
<script>var slideshow = remark.create({
"ratio": "16:9",
"highlightStyle": "github",
"highlightLines": true,
"countIncrementalSlides": false
});
if (window.HTMLWidgets) slideshow.on('afterShowSlide', function (slide) {
  window.dispatchEvent(new Event('resize'));
});
(function(d) {
  var s = d.createElement("style"), r = d.querySelector(".remark-slide-scaler");
  if (!r) return;
  s.type = "text/css"; s.innerHTML = "@page {size: " + r.style.width + " " + r.style.height +"; }";
  d.head.appendChild(s);
})(document);

(function(d) {
  var el = d.getElementsByClassName("remark-slides-area");
  if (!el) return;
  var slide, slides = slideshow.getSlides(), els = el[0].children;
  for (var i = 1; i < slides.length; i++) {
    slide = slides[i];
    if (slide.properties.continued === "true" || slide.properties.count === "false") {
      els[i - 1].className += ' has-continuation';
    }
  }
  var s = d.createElement("style");
  s.type = "text/css"; s.innerHTML = "@media print { .has-continuation { display: none; } }";
  d.head.appendChild(s);
})(document);
// delete the temporary CSS (for displaying all slides initially) when the user
// starts to view slides
(function() {
  var deleted = false;
  slideshow.on('beforeShowSlide', function(slide) {
    if (deleted) return;
    var sheets = document.styleSheets, node;
    for (var i = 0; i < sheets.length; i++) {
      node = sheets[i].ownerNode;
      if (node.dataset["target"] !== "print-only") continue;
      node.parentNode.removeChild(node);
    }
    deleted = true;
  });
})();
// add `data-at-shortcutkeys` attribute to <body> to resolve conflicts with JAWS
// screen reader (see PR #262)
(function(d) {
  let res = {};
  d.querySelectorAll('.remark-help-content table tr').forEach(tr => {
    const t = tr.querySelector('td:nth-child(2)').innerText;
    tr.querySelectorAll('td:first-child .key').forEach(key => {
      const k = key.innerText;
      if (/^[a-z]$/.test(k)) res[k] = t;  // must be a single letter (key)
    });
  });
  d.body.setAttribute('data-at-shortcutkeys', JSON.stringify(res));
})(document);
(function() {
  "use strict"
  // Replace <script> tags in slides area to make them executable
  var scripts = document.querySelectorAll(
    '.remark-slides-area .remark-slide-container script'
  );
  if (!scripts.length) return;
  for (var i = 0; i < scripts.length; i++) {
    var s = document.createElement('script');
    var code = document.createTextNode(scripts[i].textContent);
    s.appendChild(code);
    var scriptAttrs = scripts[i].attributes;
    for (var j = 0; j < scriptAttrs.length; j++) {
      s.setAttribute(scriptAttrs[j].name, scriptAttrs[j].value);
    }
    scripts[i].parentElement.replaceChild(s, scripts[i]);
  }
})();
(function() {
  var links = document.getElementsByTagName('a');
  for (var i = 0; i < links.length; i++) {
    if (/^(https?:)?\/\//.test(links[i].getAttribute('href'))) {
      links[i].target = '_blank';
    }
  }
})();
// adds .remark-code-has-line-highlighted class to <pre> parent elements
// of code chunks containing highlighted lines with class .remark-code-line-highlighted
(function(d) {
  const hlines = d.querySelectorAll('.remark-code-line-highlighted');
  const preParents = [];
  const findPreParent = function(line, p = 0) {
    if (p > 1) return null; // traverse up no further than grandparent
    const el = line.parentElement;
    return el.tagName === "PRE" ? el : findPreParent(el, ++p);
  };

  for (let line of hlines) {
    let pre = findPreParent(line);
    if (pre && !preParents.includes(pre)) preParents.push(pre);
  }
  preParents.forEach(p => p.classList.add("remark-code-has-line-highlighted"));
})(document);</script>

<script>
slideshow._releaseMath = function(el) {
  var i, text, code, codes = el.getElementsByTagName('code');
  for (i = 0; i < codes.length;) {
    code = codes[i];
    if (code.parentNode.tagName !== 'PRE' && code.childElementCount === 0) {
      text = code.textContent;
      if (/^\\\((.|\s)+\\\)$/.test(text) || /^\\\[(.|\s)+\\\]$/.test(text) ||
          /^\$\$(.|\s)+\$\$$/.test(text) ||
          /^\\begin\{([^}]+)\}(.|\s)+\\end\{[^}]+\}$/.test(text)) {
        code.outerHTML = code.innerHTML;  // remove <code></code>
        continue;
      }
    }
    i++;
  }
};
slideshow._releaseMath(document);
</script>
<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
(function () {
  var script = document.createElement('script');
  script.type = 'text/javascript';
  script.src  = 'https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML';
  if (location.protocol !== 'file:' && /^https?:/.test(script.src))
    script.src  = script.src.replace(/^https?:/, '');
  document.getElementsByTagName('head')[0].appendChild(script);
})();
</script>
  </body>
</html>
